Cedar Brook Financial Partners, LLC Novo Nordisk A S Transaction History

Cedar Brook Financial Partners, LLC

$698 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$102.11 - $135.92 $8,475 - $11,281	83 Added 1.3%	6,472 $831,000
Q4 2023 Jan 12, 2024	SELL	$87.78 - $105.45 $144,485 - $173,570	-1,646 Reduced 20.49%	6,389 $660,000
Q3 2023 Oct 17, 2023	BUY	$90.94 - $199.54 $351,301 - $770,823	3,863 Added 92.59%	8,035 $730,000
Q2 2023 Jul 05, 2023	SELL	$155.98 - $172.65 $3,275 - $3,625	-21 Reduced 0.5%	4,172 $675,000
Q1 2023 Apr 04, 2023	BUY	$132.34 - $159.14 $80,065 - $96,279	605 Added 16.86%	4,193 $667,000
Q4 2022 Feb 01, 2023	SELL	$102.55 - $135.33 $15,279 - $20,164	-149 Reduced 3.99%	3,588 $485,000
Q3 2022 Jan 03, 2023	SELL	$95.28 - $116.93 $66,696 - $81,851	-700 Reduced 15.78%	3,737 $372,000
Q2 2022 Aug 12, 2022	BUY	$103.24 - $121.81 $13,317 - $15,713	129 Added 2.99%	4,437 $494,000
Q1 2022 Apr 06, 2022	BUY	$93.1 - $112.54 $18,713 - $22,620	201 Added 4.89%	4,308 $478,000
Q4 2021 Jan 27, 2022	SELL	$95.88 - $117.08 $1,821 - $2,224	-19 Reduced 0.46%	4,107 $460,000
Q3 2021 Nov 01, 2021	SELL	$84.42 - $106.62 $12,578 - $15,886	-149 Reduced 3.49%	4,126 $396,000
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $43,573 - $54,585	-644 Reduced 13.09%	4,275 $358,000
Q1 2021 May 11, 2021	SELL	$67.06 - $75.82 $11,534 - $13,041	-172 Reduced 3.38%	4,919 $332,000
Q4 2020 Feb 12, 2021	BUY	$63.89 - $73.8 $26,706 - $30,848	418 Added 8.95%	5,091 $356,000
Q3 2020 Nov 09, 2020	SELL	$63.69 - $70.22 $17,705 - $19,521	-278 Reduced 5.62%	4,673 $324,000
Q2 2020 Aug 05, 2020	BUY	$58.54 - $67.94 $12,937 - $15,014	221 Added 4.67%	4,951 $324,000
Q1 2020 May 07, 2020	BUY	$49.46 - $64.78 $19,388 - $25,393	392 Added 9.04%	4,730 $285,000
Q4 2019 Feb 06, 2020	SELL	$49.86 - $58.26 $2,891 - $3,379	-58 Reduced 1.32%	4,338 $251,000
Q3 2019 Oct 24, 2019	SELL	$47.54 - $53.43 $47 - $53	-1 Reduced 0.02%	4,396 $227,000
Q2 2019 Aug 06, 2019	SELL	$46.79 - $52.47 $2,152 - $2,413	-46 Reduced 1.04%	4,397 $224,000
Q1 2019 May 08, 2019	BUY	$46.36 - $52.63 $205,977 - $233,835	4,443 New	4,443 $232,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$1.76 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.26 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.25 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.16 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.07 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.

Account